Loading clinical trials...
Loading clinical trials...
A Multicenter, Single-Arm, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults
Conditions
Interventions
Duobrii 0.01 % / 0.045 % Topical Lotion
CeraVe, Topical Cream
Locations
2
United States
Austin Institute for Clinical Research, Inc.
Houston, Texas, United States
Austin Institute for Clinical Research, Inc.
Pflugerville, Texas, United States
Start Date
January 13, 2022
Primary Completion Date
October 4, 2023
Completion Date
October 4, 2023
Last Updated
July 19, 2024
NCT07474792
NCT06979453
NCT07116967
NCT07250802
NCT07449702
NCT07290569
Lead Sponsor
Austin Institute for Clinical Research
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions